4.5 Article

Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1

Journal

HUMAN MOLECULAR GENETICS
Volume 22, Issue 4, Pages 696-703

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/hmg/dds477

Keywords

-

Funding

  1. Eunice Kennedy Shriver National Institute of Child Health, National Institutes of Health [K08HD053476-01A1]

Ask authors/readers for more resources

Focal facial dermal dysplasia (FFDD) Type IV is a rare syndrome characterized by facial lesions resembling aplasia cutis in a preauricular distribution along the line of fusion of the maxillary and mandibular prominences. To identify the causative gene(s), exome sequencing was performed in a family with two affected siblings. Assuming autosomal recessive inheritance, two novel sequence variants were identified in both siblings in CYP26C1ua duplication of seven base pairs, which was maternally inherited, c.844_851dupCCATGCA, predicting p.Glu284fsX128 and a missense mutation, c.1433GA, predicting p.Arg478His, that was paternally inherited. The duplication predicted a frameshift mutation that led to a premature stop codon and premature chain termination, whereas the missense mutation was not functional based on its in vitro expression in mammalian cells. The FFDD skin lesions arise along the sites of fusion of the maxillary and mandibular prominences early in facial development, and Cyp26c1 was expressed exactly along the fusion line for these facial prominences in the first branchial arch in mice. Sequencing of four additional, unrelated Type IV FFDD patients and eight Type II or III TWIST2-negative FFDD patients revealed that three of the Type IV patients were homozygous for the duplication, whereas none of the Type II or III patients had CYP26C1 mutations. The seven base pairs duplication was present in 0.3 of healthy controls and 0.3 of patients with other birth defects. These findings suggest that the phenotypic manifestations of FFDD Type IV can be non-penetrant or underascertained. Thus, FFDD Type IV results from the loss of function mutations in CYP26C1.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity

Joonhee Park, Jay Daniels, Tim Wartewig, Kimberly G. Ringbloom, Maria Estela Martinez-Escala, Sara Choi, Jane J. Thomas, Peter G. Doukas, Jingyi Yang, Caroline Snowden, Calvin Law, Yujin Lee, Katie Lee, Yancong Zhang, Carly Conran, Kyle Tegtmeyer, Samuel H. Mo, David R. Pease, Balaji Jothishankar, Pui-Yan Kwok, Farah R. Abdulla, Barbara Pro, Abner Louissaint, Titus J. Boggon, Jeffrey Sosman, Joan Guitart, Deepak Rao, Juergen Ruland, Jaehyuk Choi

Summary: The study identified 86 putative driver genes in CTCL, including 19 genes not previously implicated in the disease and two mutations never described in any cancer. Functional assays revealed that these mutations enhance T-cell receptor-dependent proliferation, highlighting their importance in lymphomagenesis. Investigations into genetic causes of CTCL heterogeneity found that while there are broad similarities across disease stages, there are significantly more structural variants in leukemic disease, leading to highly recurrent deletions of putative tumor suppressors.

BLOOD (2021)

Letter Dermatology

Cutaneous vascular anomalies associated with a mosaic variant of AKT3: Genetic analysis continues to refine the diagnosis, nomenclature, and classification of vascular anomalies

Olivia M. T. Davies, Maria C. Garzon, Ilona J. Frieden, Catherine E. Cottrell, Karen W. Gripp, Russell P. Saneto, Tor Shwayder, Ghayda M. Mizaa, Beth A. Drolet

Summary: This article mainly focuses on surgical treatment for male genital tumors, including local recurrence rates and a review of cases. It also explores the surgical treatment and reconstruction for genital skin cancer, as well as the surgical treatment and outcomes of patients with extramammary Paget's disease.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Article Psychiatry

Genome-wide association study of early-onset bipolar I disorder in the Han Taiwanese population

Lawrence Shih-Hsin Wu, Ming-Chyi Huang, Cathy Shen-Jang Fann, Hsien-Yuan Lane, Chian-Jue Kuo, Wei-Che Chiu, Pui-Yan Kwok, Andrew Tai-Ann Cheng

Summary: The study conducted a genome-wide association study for early-onset bipolar I disorder in patients of Han Chinese descent, revealing an association between the SNP rs11127876 in the intron of CADM2 gene and early-onset BPI.

TRANSLATIONAL PSYCHIATRY (2021)

Article Psychiatry

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration

Ruin Moaddel, Panos Zanos, Cristan A. Farmer, Bashkim Kadriu, Patrick J. Morris, Jacqueline Lovett, Elia E. Acevedo-Diaz, Grace W. Cavanaugh, Peixiong Yuan, Mani Yavi, Craig J. Thomas, Lawrence T. Park, Luigi Ferrucci, Todd D. Gould, Carlos A. Zarate

Summary: Subanesthetic-dose ketamine has rapid and sustained antidepressant effects, and its metabolite (2 R,6 R)-HNK also exhibits similar effects. Metabolomic analysis reveals the involvement of inflammatory pathways in the effects of ketamine and (2 R,6 R)-HNK, with potential differences between mice and humans.

TRANSLATIONAL PSYCHIATRY (2022)

Article Dermatology

Successful use of telemedicine for evaluation of infantile hemangiomas during the early COVID-19 pandemic: A cross-sectional study

Nicole W. Kittler, Ilona J. Frieden, Katrina Abuabara, Dawn H. Siegel, Kimberly A. Horii, Erin F. Mathes, Francine Blei, Anita N. Haggstrom, Jenna L. Streicher, Denise W. Metry, Maria C. Garzon, Kimberly D. Morel, Christine T. Lauren, Marcia Hogeling, Esteban Fernandez Faith, Eulalia Baselga, Megha M. Tollefson, Brandon D. Newell, Catherine C. McCuaig, Anthony J. Mancini, Sarah L. Chamlin, Emily M. Becker, Maria L. Cossio, Sonal D. Shah

Summary: The study found that during the COVID-19 pandemic, hemangioma specialists utilized telemedicine for evaluating and managing IH with high confidence, mostly through video or audio communication with photographs. Providers preferred follow-up modalities that included photographs, and the data suggest that telemedicine can effectively manage IH and potentially reduce wait times.

PEDIATRIC DERMATOLOGY (2022)

Article Dermatology

Early-onset hypertension associated with extensive cutaneous capillary malformations harboring postzygotic variants in GNAQ and GNA11

Olivia M. T. Davies, Ashley T. Ng, Jennifer Tran, Shoshana Blumenthal, Lisa M. Arkin, Amy J. Nopper, Catherine E. Cottrell, Maria Garzon, Dawn H. Siegel, Ilona J. Frieden, Beth A. Drolet

Summary: This study reports five patients with early-onset hypertension and extensive cutaneous capillary malformations (CMs), and discusses possible mechanisms driving hypertension. The study recommends serial blood pressure measurements in patients with extensive CMs on the trunk and extremities to screen for early-onset hypertension.

PEDIATRIC DERMATOLOGY (2022)

Article Dermatology

Incidence and clinical factors associated with ulceration in infantile hemangiomas

Esteban Fernandez Faith, Sonal D. Shah, Mitchell Braun, Elena Pope, Irene Lara-Corrales, Patricia M. Witman, Katya Harfmann, Flora Bradley, Rohali Keesari, Kenneth Jackson, Alexandra Hallagan, Ilona J. Frieden

Summary: This retrospective study found that the incidence of ulceration in infantile hemangiomas has decreased compared to previous reports. However, it remains a relatively common complication. Clinical factors associated with ulceration include partial segmental morphology, location in the diaper area, and size greater than 5 cm. Additionally, Black patients were found to have a higher risk of ulceration, potentially due to barriers to care.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

Review Dermatology

Multicenter retrospective review of pulsed dye laser in nonulcerated infantile hemangioma

Sonal D. Shah, Erin F. Mathes, Eulalia Baselga, Ilona J. Frieden, Julie Powell, Maria C. Garzon, Kimberly D. Morel, Christine T. Lauren, Anthony J. Mancini, Sarah L. Chamlin, Monica Rios, Lina Belmesk, Catherine C. McCuaig

Summary: This study describes the experience of the Hemangioma Investigator Group with pulsed dye laser (PDL) in treating nonulcerated infantile hemangioma (IH) in pediatric patients. The results show that PDL is a useful tool in the treatment of IH, with significant improvement in telangiectasia and erythema and low risk of complications.

PEDIATRIC DERMATOLOGY (2023)

Article Oncology

Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response

Elissa R. Engel, Adrienne Hammill, Denise Adams, Roderic J. Phillips, Michael Jeng, Megha M. Tollefson, Ionela Iacobas, Deborah Schiff, Shoshana Greenberger, Michael Kelly, Ilona Frieden, Nibal Zaghloul, Beth Drolet, Amy Geddis, Dov Goldenberg, Kiersten Ricci

Summary: Sirolimus therapy is safe and effective in reducing complications and improving quality of life in patients with capillary lymphatic venous malformations and associated syndromes.

PEDIATRIC BLOOD & CANCER (2023)

Article Dermatology

Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate

Christine Leaute-Labreze, Ilona Frieden, Alain Delarue

Summary: Early referral and treatment of infantile hemangioma is challenging, and there is a lack of data on the optimal timing for initiating treatment with oral propranolol. This study found that starting oral propranolol before 10 weeks of age was associated with a significantly higher treatment success rate of 86%, compared to a success rate of 60% when starting treatment after 10 weeks of age.

PEDIATRIC DERMATOLOGY (2023)

Letter Oncology

Letter to editor regarding Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument

Ilona J. J. Frieden, Anthony J. J. Mancini, Francine Blei, David H. Darrow, Daniel P. P. Krowchuk

PEDIATRIC HEMATOLOGY AND ONCOLOGY (2023)

Article Medicine, Research & Experimental

Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition

Sarah E. Sheppard, Michael E. March, Christoph Seiler, Leticia S. Matsuoka, Sophia E. Kim, Charlly Kao, Adam I. Rubin, Mark R. Battig, Nahla Khalek, Erica Schindewolf, Nora O'Connor, Erin Pinto, Jessica R. C. Priestley, Victoria R. Sanders, Rojeen Niazi, Arupa Ganguly, Cuiping Hou, Diana Slater, Ilona J. Frieden, Thy Huynh, Joseph T. Shieh, Ian D. Krantz, Jessenia C. Guerrero, Lea F. Surrey, David M. Biko, Pablo Laje, Leslie Castelo-Soccio, Taizo A. Nakano, Kristen Snyder, Christopher L. Smith, Dong Li, Yoav Dori, Hakon Hakonarson

Summary: Central conducting lymphatic anomaly (CCLA), a debilitating and potentially life-threatening disease, can be caused by congenital maldevelopment of the lymphatics. Through studying individuals with CCLA and microcystic lymphatic malformation, researchers identified pathogenic KRAS variants, which activate the RAS/MAPK pathway. Using cell and animal models, they found that MEK inhibition could effectively reduce lymphatic dysplasia and edema. These findings suggest that MEK inhibition should be further investigated as a targeted therapy for CCLA caused by activating KRAS pathogenic variants.

JCI INSIGHT (2023)

Article Oncology

EML4::ALK fusions in complex lymphatic malformations

Beth Apsel Winger, Walter Patrick Devine, Edward C. Hsiao, Matthew Zapala, Jessica Van Ziffle, Nalin Gupta, Ilona J. Frieden, Kristin A. Shimano

Summary: Gorham-Stout disease (GSD) and generalized lymphatic anomaly (GLA) are subtypes of complex lymphatic malformations (CLMs) with osseous involvement. Somatic mosaic mutations in oncogenes are often present, and targeted therapies such as mTOR inhibitors may alleviate symptoms in some patients. The discovery of EML4::ALK fusions in two patients with GSD and GLA suggests additional targeted therapies could be effective.

PEDIATRIC BLOOD & CANCER (2023)

Article Oncology

Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK)

Ifeoma U. Perkins, Serena Y. Tan, Timothy H. McCalmont, Pauline M. Chou, Thaddeus W. Mully, Pedram Gerami, Jason H. Pomerantz, Miguel Reyes-Mugica, Daniel M. Balkin, Lacey L. Kruse, Benjamin Huang, Jennifer L. Reichek, Noopur Gangopadhyay, Simon Chiosea, Jared R. Green, Sarah L. Chamlin, Ilona J. Frieden, Boris C. Bastian, Iwei Yeh

Summary: We report the first cases of pediatric melanoma with ALK fusion gene arising within giant congenital melanocytic nevi. Two newborn boys presented with large pigmented nodular plaques and numerous smaller satellite nevi. Instead of NRAS and BRAF mutations, oncogenic ZEB2::ALK fusion genes were identified in both the nevus and melanoma developing within the nevus, suggesting a more aggressive behavior.

PIGMENT CELL & MELANOMA RESEARCH (2023)

Article Dermatology

A practical guide to clinical photography prior to skin biopsy: key tips and proposed workflow

Keemberly Kim, Sampreet Reddy, Lindsay J. Osborn, Ilona C. Frieden, Kelly W. Nelson, Matilda E. Nicholas, Elizabeth Bailey, Meghan Dickman

Summary: High-quality clinical photography is essential in dermatology for patient evaluation, clinical teaching, and research. Though smartphones have made photography more accessible, there are challenges in obtaining quality photos. This guide proposes best practices for image capture to improve patient care and integrate high-quality photography into routine clinical practice.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2023)

No Data Available